文献速递肝病消化道肿瘤与早癌

不确定潜能的克隆性造血对脂肪性肝病个体肝细胞癌的影响

Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease.
PubMed 文献 · Hepatology · 2024-03-11

本研究纳入代谢功能障碍相关脂肪性肝病(MASLD)相关肝细胞癌(HCC)患者208例、伴晚期纤维化的对照414例及不伴晚期纤维化的对照259例,进行全外显子测序。结果显示CHIP与肝硬化(OR 2.00)及HCC(OR 1.81)独立相关,非DNMT3A的CHIP及TET2病变在充分校正后仍与HCC相关。

要点

  • CHIP在116例(13.1%)中检出,最常见于DNMT3A、TET2、TP53和ASXL1。
  • CHIP与年龄(p<0.0001)及晚期肝纤维化(p=0.001)相关。
  • 校正混杂因素后,CHIP与肝硬化(OR 2.00)及HCC(OR 1.81)独立相关。

核心结论

  • 观察到CHIP,特别是非DNMT3A及TET2遗传病变,与MASLD-HCC存在独立关联。

研究设计与样本

  • 纳入MASLD-HCC患者208例、伴晚期纤维化的对照414例及不伴晚期纤维化的对照259例,进行全外显子测序。
  • CHIP定义为≥2个变异识别工具检出已知髓系突变且变异等位基因频率≥2%。

主要发现

  • CHIP在116例参与者(13.1%)中检出,最常见于DNMT3A、TET2、TP53和ASXL1。
  • CHIP与年龄(p<0.0001)及晚期肝纤维化(p=0.001)相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a global epidemic and is the most rapidly rising cause of HCC. Clonal hematopoiesis of indeterminate potential (CHIP) contributes to neoplastic and cardiometabolic disorders and is considered a harbinger of tissue inflammation. CHIP was recently associated with increased risk of liver disease. The aim of this study was to examine whether CHIP is associated with HCC development in patients with SLD. APPROACH AND RESULTS: We considered individuals with MASLD-HCC (n=208) and controls with (n =414) and without (n =259) advanced fibrosis who underwent whole exome sequencing. CHIP was diagnosed when ≥2 variant callers identified a known myeloid mutation with variant allele frequency ≥2%. CHIP was observed in 116 participants (13.1%), most frequently in DNMT3A, TET2, TP53 , and ASXL1 , and correlated with age ( p <0.0001) and advanced liver fibrosis (p=0.001). Higher aspartate aminotransferase levels predicted non- DNMT3A -CHIP, in particular with variant allele frequency ≥10% (OR: 1.14, 1.03 -1.28 and OR: 1.30, 1.12 -1.49, respectively, p <0.05). After adjustment for sex, diabetes, and a polygenic risk, a score of inherited MASLD predisposition CHIP was associated with cirrhosis (2.00, 1.30 -3.15, p =0.02), and with HCC even after further adjustment for cirrhosis (OR: 1.81, 1.11 -2.00, 1.30 -3.15, p =0.002). Despite the strong collinearity among aging and development of CHIP and HCC, non- DNTM3A -CHIP, and TET2 lesions remained associated with HCC after full correction for clinical/genetics covariates and age (OR: 2.45, 1.35 -4.53; OR: 4.8, 1.60 -17.0, p =0.02). CONCLUSIONS: We observed an independent association between CHIP, particularly related to non- DNTM3A and TET2 genetic lesions and MASLD-HCC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Marchetti A, Pelusi S, Marella A, et al. Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease. Hepatology. 2024. PMID: 38470216. doi:10.1097/HEP.0000000000000839

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。